Novel biomarkers for predicting intrauterine growth restriction: a systematic review and meta‐analysis

Several biomarkers for predicting intrauterine growth restriction (IUGR) have been proposed in recent years. However, the predictive performance of these biomarkers has not been systematically evaluated.

[1]  E. Bennett,et al.  The first trimester. , 1984, JOGN nursing; journal of obstetric, gynecologic, and neonatal nursing.

[2]  J. Grudzinskas,et al.  Placental protein measurements in complicated pregnancies. I. Intrauterine growth retardation , 1984, British journal of obstetrics and gynaecology.

[3]  S. Bewley,et al.  Early prediction of uteroplacental complications of pregnancy using Doppler ultrasound, placental function tests and combination testing , 1992, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[4]  G. Guyatt,et al.  Users' guides to the medical literature. , 1993, JAMA.

[5]  G. Guyatt,et al.  Users' Guides to the Medical Literature: III. How to Use an Article About a Diagnostic Test: B. What Are the Results and Will They Help Me In Caring for My Patients? , 1994 .

[6]  G. Guyatt,et al.  Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. , 1994, JAMA.

[7]  Lisa A. Weissfeld,et al.  An assessment of the use of the continuity correction for sparse data in meta-analysis , 1996 .

[8]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[9]  D. Charnock-Jones,et al.  Hepatocyte growth factor levels during normal and intra-uterine growth-restricted pregnancies. , 1998, Placenta.

[10]  M. Blössner,et al.  Levels and patterns of intrauterine growth retardation in developing countries. , 1998, European journal of clinical nutrition.

[11]  P. Bossuyt,et al.  Empirical evidence of design-related bias in studies of diagnostic tests. , 1999, JAMA.

[12]  S. Hamdani,et al.  Intrauterine growth retardation , 2000 .

[13]  C. Oudejans,et al.  Plasma Placenta Growth Factor Levels in Midtrimester Pregnancies , 2001, Obstetrics and gynecology.

[14]  Y. Zhu,et al.  The predictive value of plasma fibronectin concentration on fetal growth retardation at earlier stage of the third trimester. , 2001, Journal of Tongji Medical University = Tong ji yi ke da xue xue bao.

[15]  T. Kubo,et al.  The Relation between Plasma Homocysteine Concentration and Methylenetetrahydrofolate Reductase Gene Polymorphism in Pregnant Women , 2001, The journal of obstetrics and gynaecology research.

[16]  Gynecologists,et al.  Intrauterine growth restriction. Clinical management guidelines for obstetrician-gynecologists. American College of Obstetricians and Gynecologists. , 2001, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[17]  R. Resnik.  Intrauterine growth restriction. , 2002, Obstetrics and gynecology.

[18]  Patrick M M Bossuyt,et al.  Exploring sources of heterogeneity in systematic reviews of diagnostic tests , 2002, Statistics in medicine.

[19]  S. Walter,et al.  Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data , 2002, Statistics in medicine.

[20]  H. Augustin,et al.  Predictive value of routine circulating soluble endothelial cell adhesion molecule measurements during pregnancy. , 2002, Clinical chemistry.

[21]  D. Rennie,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative , 2003, BMJ : British Medical Journal.

[22]  M. Blankenstein,et al.  Plasma hepatocyte growth factor as a marker for small-for-gestational age fetuses. , 2003, European journal of obstetrics, gynecology, and reproductive biology.

[23]  P. Bossuyt,et al.  BMC Medical Research Methodology , 2002 .

[24]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[25]  M. Blankenstein,et al.  Markers for Presymptomatic Prediction of Preeclampsia and Intrauterine Growth Restriction , 2004, Hypertension in pregnancy.

[26]  Jason Gardosi,et al.  Perinatal mortality and fetal growth restriction. , 2004, Best practice & research. Clinical obstetrics & gynaecology.

[27]  R. Ientile,et al.  Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction , 2004, Acta obstetricia et gynecologica Scandinavica.

[28]  K. Nicolaides,et al.  First-trimester maternal serum activin A in pre-eclampsia and fetal growth restriction , 2004, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[29]  H. Augustin,et al.  Prospective Analysis of Placenta Growth Factor (PlGF) Concentrations in the Plasma of Women with Normal Pregnancy and Pregnancies Complicated by Preeclampsia , 2004, Hypertension in pregnancy.

[30]  Robert N. Taylor,et al.  First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. , 2004, The Journal of clinical endocrinology and metabolism.

[31]  N. Bersinger,et al.  Second‐ and third‐trimester serum levels of placental proteins in preeclampsia and small‐for‐gestational age pregnancies , 2004, Acta obstetricia et gynecologica Scandinavica.

[32]  N. Bersinger,et al.  Serum Levels of Macrophage Colony Stimulating, Vascular Endothelial, and Placenta Growth Factor in Relation to Later Clinical Onset of Pre‐Eclampsia and a Small‐for‐Gestational Age Birth , 2005, American journal of reproductive immunology.

[33]  Penny Whiting,et al.  Bmc Medical Research Methodology Open Access No Role for Quality Scores in Systematic Reviews of Diagnostic Accuracy Studies , 2005 .

[34]  Johannes B Reitsma,et al.  Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. , 2005, Journal of clinical epidemiology.

[35]  G. Buonocore,et al.  Isoprostanes in amniotic fluid: a predictive marker for fetal growth restriction in pregnancy. , 2005, Free radical biology & medicine.

[36]  Eugenia K. Pallotto,et al.  Perinatal Outcome and Later Implications of Intrauterine Growth Restriction , 2006, Clinical obstetrics and gynecology.

[37]  D. Barker,et al.  Adult Consequences of Fetal Growth Restriction , 2006, Clinical obstetrics and gynecology.

[38]  D. Wojdyla,et al.  Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? , 2006, American journal of obstetrics and gynecology.

[39]  E. Karabulut,et al.  Combining 2nd-Trimester Maternal Serum Homocysteine Levels and Uterine Artery Doppler for Prediction of Preeclampsia and Isolated Intrauterine Growth Restriction , 2006, Gynecologic and Obstetric Investigation.

[40]  J. Rand,et al.  Annexin A5 levels in midtrimester amniotic fluid: association with intrauterine growth restriction. , 2006, American journal of obstetrics and gynecology.

[41]  M. Wolf,et al.  First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. , 2007, American journal of obstetrics and gynecology.

[42]  J. Morris,et al.  Reduced maternal serum concentrations of angiopoietin‐2 in the first trimester precede intrauterine growth restriction associated with placental insufficiency , 2007, BJOG : an international journal of obstetrics and gynaecology.

[43]  R. Romero,et al.  Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. , 2007, American journal of obstetrics and gynecology.

[44]  E. Funai.  Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? , 2007 .

[45]  C. Lees,et al.  Prediction and perinatal outcomes of fetal growth restriction. , 2007, Seminars in fetal & neonatal medicine.

[46]  Ariel J. Jaffa,et al.  Neurodevelopmental Outcome of Children With Intrauterine Growth Retardation: A Longitudinal, 10-Year Prospective Study , 2007, Journal of child neurology.

[47]  N. Wessel,et al.  Predictive Value of Maternal Angiogenic Factors in Second Trimester Pregnancies With Abnormal Uterine Perfusion , 2007, Hypertension.

[48]  K. Spencer,et al.  First‐trimester ADAM12 and PAPP‐A as markers for intrauterine fetal growth restriction through their roles in the insulin‐like growth factor system , 2007, Prenatal diagnosis.

[49]  K. Nicolaides,et al.  Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11+0 to 13+6 weeks of gestation , 2008, Prenatal diagnosis.

[50]  B. No̸rgaard-Pedersen,et al.  First‐trimester combined screening for Down syndrome: prediction of low birth weight, small for gestational age and pre‐term delivery in a cohort of non‐selected women , 2008, Prenatal diagnosis.

[51]  Wenjiang J. Fu,et al.  The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age , 2008, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[52]  B. Spur,et al.  Oxidative stress early in pregnancy and pregnancy outcome , 2008, Free radical research.

[53]  K. Nicolaides,et al.  First-Trimester Maternal Serum a Disintegrin and Metalloprotease 12 (ADAM12) and Adverse Pregnancy Outcome , 2008, Obstetrics and gynecology.

[54]  A. Diab,et al.  Angiogenic factors for the prediction of pre‐eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry , 2008, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[55]  J. Kleijnen,et al.  Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis. , 2008, BMC pregnancy and childbirth.

[56]  Wang Zehua,et al.  The predictive value of plasma fibronectin concentration on fetal growth retardation at earlier stage of the third trimester , 2008, Journal of Tongji Medical University.

[57]  K. Joseph,et al.  Effect of homocysteine concentration in early pregnancy on gestational hypertensive disorders and other pregnancy outcomes. , 2008, Clinical chemistry.

[58]  Philipp Dahm,et al.  Evidence-Based Surgery Chirurgie factuelle Users ’ guides to the surgical literature : how to use an article about a diagnostic test , 2001 .

[59]  K. Nicolaides,et al.  First‐trimester biochemical markers of aneuploidy and the prediction of small‐for‐gestational age fetuses , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[60]  James M. Roberts,et al.  Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants. , 2008, American journal of obstetrics and gynecology.

[61]  Patrick M Bossuyt,et al.  We should not pool diagnostic likelihood ratios in systematic reviews , 2008, Statistics in medicine.

[62]  M. Christiansen,et al.  First trimester maternal serum PAPP‐A, β‐hCG and ADAM12 in prediction of small‐for‐gestational‐age fetuses , 2008, Prenatal diagnosis.

[63]  A. Odibo,et al.  The efficiency of first-trimester serum analytes and maternal characteristics in predicting fetal growth disorders. , 2009, American journal of obstetrics and gynecology.

[64]  A. Abdollahi,et al.  Predictive value of mid-trimester amniotic fluid high-sensitive C-reactive protein, ferritin, and lactate dehydrogenase for fetal growth restriction. , 2009, Indian journal of pathology & microbiology.

[65]  A. Arossa,et al.  The Impact of First-Trimester Serum Free β-Human Chorionic Gonadotropin and Pregnancy-Associated Plasma Protein A on the Diagnosis of Fetal Growth Restriction and Small for Gestational Age Infant , 2009, Fetal Diagnosis and Therapy.

[66]  P. Hohlfeld,et al.  Amniotic fluid insulin-like growth factor binding protein 3 concentration as early indicator of fetal growth restriction. , 2009, European journal of obstetrics, gynecology, and reproductive biology.

[67]  A. Papageorghiou,et al.  First trimester PTX3 levels in women who subsequently develop preeclampsia and fetal growth restriction , 2009, Acta obstetricia et gynecologica Scandinavica.

[68]  G. Velásquez-Melendez,et al.  Low Leptin Concentration in the First Gestational Trimester Is Associated with Being Born Small for Gestational Age: Prospective Study in Rio de Janeiro, Brazil , 2009, Neonatology.

[69]  Rajinder Singh,et al.  First‐trimester increase in oxidative stress and risk of small‐for‐gestational‐age fetus , 2009, BJOG : an international journal of obstetrics and gynaecology.

[70]  M. Christiansen,et al.  First trimester maternal serum pregnancy‐specific beta‐1‐glycoprotein (SP1) as a marker of adverse pregnancy outcome , 2009, Prenatal diagnosis.

[71]  M. Gissler,et al.  Low maternal PAPP‐A is associated with small‐for‐gestational age newborns and stillbirths , 2010, Acta obstetricia et gynecologica Scandinavica.

[72]  M. Tuuli,et al.  First- and second-trimester screening for preeclampsia and intrauterine growth restriction. , 2010, Clinics in laboratory medicine.

[73]  A. Varvarigou,et al.  Intrauterine Growth Restriction as a Potential Risk Factor for Disease Onset in Adulthood , 2010, Journal of pediatric endocrinology & metabolism : JPEM.

[74]  M. Marazita,et al.  Maternal serum 25-hydroxyvitamin D concentrations are associated with small-for-gestational age births in white women. , 2010, The Journal of nutrition.

[75]  Kypros H. Nicolaides,et al.  Prediction of Small-for-Gestation Neonates from Biophysical and Biochemical Markers at 11–13 Weeks , 2010, Fetal Diagnosis and Therapy.

[76]  M. Kramer,et al.  Defining normal and abnormal fetal growth: promises and challenges. , 2010, American journal of obstetrics and gynecology.

[77]  A. Szilágyi,et al.  PP13, Maternal ABO Blood Groups and the Risk Assessment of Pregnancy Complications , 2011, PloS one.

[78]  J. Twisk,et al.  First trimester screening for intra‐uterine growth restriction and early‐onset pre‐eclampsia , 2011, Prenatal diagnosis.

[79]  A. Hofman,et al.  C-reactive protein levels in early pregnancy, fetal growth patterns, and the risk for neonatal complications: the Generation R Study. , 2011, American journal of obstetrics and gynecology.

[80]  N. Uldbjerg,et al.  Early fetal growth, PAPP‐A and free β‐hCG in relation to risk of delivering a small‐for‐gestational age infant , 2011, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[81]  M. Permezel,et al.  Association between maternal serum cytokine profiles at 7-10 weeks' gestation and birthweight in small for gestational age infants. , 2011, American journal of obstetrics and gynecology.

[82]  K. Nicolaides,et al.  Maternal thyroid function at eleven to thirteen weeks of gestation and subsequent delivery of small for gestational age neonates. , 2011, Thyroid : official journal of the American Thyroid Association.

[83]  A. Cahill,et al.  356: PP13, PAPP-A, first-trimester uterine-artery Doppler measurements, and maternal characteristics in the prediction of small for gestational age fetuses , 2011 .

[84]  S. Roberts,et al.  Prediction of pre‐eclampsia in early pregnancy by estimating the spot urinary albumin: creatinine ratio using high‐performance liquid chromatography , 2011, BJOG : an international journal of obstetrics and gynaecology.

[85]  D. Kell,et al.  Metabolic profiling uncovers a phenotypic signature of small for gestational age in early pregnancy. , 2011, Journal of proteome research.

[86]  L. Vatten,et al.  Angiogenic factors in maternal circulation and the risk of severe fetal growth restriction. , 2011, American Journal of Epidemiology.

[87]  K. Nicolaides,et al.  Maternal Serum Vitamin D at 11–13 Weeks in Pregnancies Delivering Small for Gestational Age Neonates , 2012, Fetal Diagnosis and Therapy.

[88]  W. Dunn,et al.  A Metabolomic Approach Identifies Differences in Maternal Serum in Third Trimester Pregnancies That End in Poor Perinatal Outcome , 2012, Reproductive Sciences.

[89]  W. Fraser,et al.  762: Risk for preeclampsia and intrauterine growth restriction: effective value of PlGF, Sflt-1 and Inhibin A in singleton and multiple pregnancies , 2012 .

[90]  A. Souka,et al.  First trimester prediction of small‐ and large‐for‐gestation neonates by an integrated model incorporating ultrasound parameters, biochemical indices and maternal characteristics , 2012, Acta obstetricia et gynecologica Scandinavica.

[91]  K. Nicolaides,et al.  Maternal serum placental growth hormone at 11–13 weeks’ gestation in pregnancies delivering small for gestational age neonates , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[92]  J. Kingdom,et al.  Combinations of maternal serum markers to predict preeclampsia, small for gestational age, and stillbirth: a systematic review. , 2012, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[93]  A. Hofman,et al.  Homocysteine and folate concentrations in early pregnancy and the risk of adverse pregnancy outcomes: the Generation R Study , 2012, BJOG : an international journal of obstetrics and gynaecology.

[94]  A. Papageorghiou,et al.  Novel Biomarkers for the Prediction of the Spontaneous Preterm Birth Phenotype: A Systematic Review and Meta-analysis , 2012 .

[95]  J. Morris,et al.  First trimester screening of maternal placental protein 13 for predicting preeclampsia and small for gestational age: in-house study and systematic review. , 2012, Placenta.

[96]  L. Magee,et al.  Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction? , 2012, American journal of obstetrics and gynecology.